Unknown

Dataset Information

0

RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism.


ABSTRACT:

Rationale

Vascular endothelial growth factor (VEGF) regulates vascular, inflammatory, remodeling, and cell death responses. It plays a critical role in normal pulmonary physiology, and VEGF excess and deficiency have been implicated in the pathogenesis of asthma and chronic obstructive pulmonary disease, respectively. Although viruses are an important cause of chronic obstructive pulmonary disease exacerbations and innate responses play an important role in these exacerbations, the effects of antiviral responses on VEGF homeostasis have not been evaluated.

Objectives

We hypothesized that antiviral innate immunity regulates VEGF tissue responses.

Methods

We compared the effects of transgenic VEGF(165) in mice treated with viral pathogen-associated molecular pattern polyinosinic:polycytidylic acid [poly(I:C)], mice treated with live virus, and control mice.

Measurements and main results

Transgenic VEGF stimulated angiogenesis, edema, inflammation, and mucin accumulation. Each of these was abrogated by poly(I:C). These inhibitory effects were dose dependent, noted when poly(I:C) was administered before and after transgene activation, and mediated by a Toll-like receptor-3-independent and RIG-like helicase (RLH)- and type I IFN receptor-dependent pathway. VEGF stimulated the expression of VEGF receptor-1 and poly(I:C) inhibited this stimulation. Poly(I:C) also inhibited the ability of VEGF to activate extracellular signal-regulated kinase-1, Akt, focal adhesion kinase, and endothelial nitric oxide synthase, and aeroallergen-induced adaptive helper T-cell type 2 inflammation. Influenza and respiratory syncytial virus also inhibited VEGF-induced angiogenesis.

Conclusions

These studies demonstrate that poly(I:C) and respiratory viruses inhibit VEGF-induced tissue responses and adaptive helper T-cell type 2 inflammation and highlight the importance of a RLH- and type I IFN receptor-dependent pathway(s) in these regulatory events. They define a novel link between VEGF and antiviral and RLH innate immune responses and a novel pathway that regulates pulmonary VEGF activity.

SUBMITTER: Ma B 

PROVIDER: S-EPMC3114061 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism.

Ma Bing B   Dela Cruz Charles S CS   Hartl Dominik D   Kang Min-Jong MJ   Takyar Shervin S   Homer Robert J RJ   Lee Chun Geun CG   Elias Jack A JA  

American journal of respiratory and critical care medicine 20110128 10


<h4>Rationale</h4>Vascular endothelial growth factor (VEGF) regulates vascular, inflammatory, remodeling, and cell death responses. It plays a critical role in normal pulmonary physiology, and VEGF excess and deficiency have been implicated in the pathogenesis of asthma and chronic obstructive pulmonary disease, respectively. Although viruses are an important cause of chronic obstructive pulmonary disease exacerbations and innate responses play an important role in these exacerbations, the effec  ...[more]

Similar Datasets

| S-EPMC5913291 | biostudies-literature
| S-EPMC7492610 | biostudies-literature
2022-03-08 | GSE168255 | GEO
| S-EPMC2851864 | biostudies-literature
| S-EPMC4490948 | biostudies-literature
| S-EPMC4517142 | biostudies-literature
| S-EPMC2613625 | biostudies-literature
| S-EPMC7770098 | biostudies-literature
| S-EPMC4208014 | biostudies-literature
| S-EPMC8396550 | biostudies-literature